Related references
Note: Only part of the references are listed.Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development
Raksha Jain et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia
Amelia Shoemark et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
Holly R. Keir et al.
LANCET RESPIRATORY MEDICINE (2021)
Ventilation Inhomogeneity and Bronchial Basement Membrane Changes in Chronic Neutrophilic Airway Inflammation
Vaclav Koucky et al.
CHEST (2020)
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
James D. Chalmers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation
J. Kirk Harris et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype
Stephanie D. Davis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Muco-Obstructive Lung Diseases
Richard C. Boucher
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Megan L. Crichton et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets
Bradley H. Rosen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Inflammation in cystic fibrosis: An update
Erica A. Roesch et al.
PEDIATRIC PULMONOLOGY (2018)
Bronchiectasis: new therapies and new perspectives
James D. Chalmers et al.
LANCET RESPIRATORY MEDICINE (2018)
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Patrick A. Flume et al.
LANCET (2018)
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia
Felix Ratjen et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
PRAGMA-CF A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis
Tim Rosenow et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Clinical Features of Childhood Primary Ciliary Dyskinesia by Genotype and Ultrastructural Phenotype
Stephanie D. Davis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Inflammation and its genesis in cystic fibrosis
David P. Nichols et al.
PEDIATRIC PULMONOLOGY (2015)
Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses
Shantelle L. LaFayette et al.
SCIENCE ADVANCES (2015)
Assessment of Airway Microbiota and Inflammation in Cystic Fibrosis Using Multiple Sampling Methods
Edith T. Zemanick et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Automated CT Scan Scores of Bronchiectasis and Air Trapping in Cystic Fibrosis
Emily M. DeBoer et al.
CHEST (2014)
Primary Ciliary Dyskinesia Recent Advances in Diagnostics, Genetics, and Characterization of Clinical Disease
Michael R. Knowles et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Risk Factors for Bronchiectasis in Children with Cystic Fibrosis
Peter D. Sly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis
Scott D. Sagel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations
Philip H. Quanjer et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation
A. Livraghi-Butrico et al.
MUCOSAL IMMUNOLOGY (2012)
Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis
Theodore G. Liou et al.
PLOS ONE (2012)
Ventilation inhomogeneity in children with primary ciliary dyskinesia
Kent Green et al.
THORAX (2012)
Lung Function in Patients with Primary Ciliary Dyskinesia A Cross-Sectional and 3-Decade Longitudinal Study
June K. Marthin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Sputum and serum calprotectin are useful biomarkers during CF exacerbation
R. D. Gray et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Impact of Pseudomonas and Staphylococcus Infection on Inflammation and Clinical Status in Young Children with Cystic Fibrosis
Scott D. Sagel et al.
JOURNAL OF PEDIATRICS (2009)
Early lung disease in young children with primary ciliary dyskinesia
David E. Brown et al.
PEDIATRIC PULMONOLOGY (2008)
Airway remodelling in children with cystic fibrosis
Tom N. Hilliard et al.
THORAX (2007)
Association between pulmonary function and sputum biomarkers in cystic fibrosis
Nicole Mayer-Hamblett et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Mucus properties in children with primary ciliary dyskinesia - Comparison with cystic fibrosis
A Bush et al.
CHEST (2006)
Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia
N Zihlif et al.
PEDIATRIC PULMONOLOGY (2005)
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
M Mall et al.
NATURE MEDICINE (2004)
Share Paper
